Notable Labs Reports 2023 Financial Results and Provides a Business Update
Notable Labs, Ltd. - Ordinary Shares (NTBL)
Company Research
Source: GlobeNewswire
FOSTER CITY, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (Nasdaq: NTBL) (“Notable” or the “Company”), a clinical-stage precision oncology company developing new cancer therapies identified by its Predictive Precision Medicine Platform (PPMP), reported financial results for the year ended December 31, 2023 and provided a business update. “The last year has been a time of great accomplishment for Notable. We built a strong clinical validation dataset, starting with a poster presented at the American Association for Cancer Research (AACR 2023); became a publicly listed company, following the closing of a reverse merger in October 2023; and reported successful PPMP clinical data from the Phase 2 fosciclopirox study that showcased the ability of our platform to accurately predict patient outcomes for specific therapeutics,” said Thomas Bock, M.D., Chief Executive Officer of Notable. “The performance of our platform in accurately predicting the outcome of the foscic
Show less
Read more
Impact Snapshot
Event Time:
NTBL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NTBL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NTBL alerts
High impacting Notable Labs, Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
NTBL
News
- Notable Labs, Ltd. (NASDAQ: NTBL) had its price target lowered by analysts at Chardan Capital from $7.00 to $5.00. They now have a "buy" rating on the stock.MarketBeat
- Notable Labs to Participate in Fireside Chat at the Citizens JMP Securities Life Sciences Conference 2024GlobeNewswire
- Notable Labs, Ltd. (NASDAQ: NTBL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $9.00 price target on the stock.MarketBeat
- Notable Labs, Ltd. (NASDAQ: NTBL) had its price target lowered by analysts at Chardan Capital from $9.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
- Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024GlobeNewswire
NTBL
Sec Filings
- 5/15/24 - Form 10-Q
- 5/10/24 - Form 4
- 5/10/24 - Form 4
- NTBL's page on the SEC website